LMRI in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with LMRI today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Lumexa Imaging Holdings, Inc. operates outpatient imaging centers in the United States where patients referred by physicians receive scans and radiologists interpret the images. This center business supplies most of its revenue, with MRI and CT contributing more than half of revenue. Commercial health insurers are the largest source of payment, followed by government programs such as Medicare and Medicaid; patients and other payors supply the remainder.
Lumexa operates both its own centers and centers jointly owned with health systems. At joint-venture centers, it earns management fees and shares in profits and cash distributions according to its ownership interest. It also has a separate professional-services business whose radiologists interpret scans performed elsewhere, mainly in hospital imaging departments.
The business depends on continued physician referrals, insurer coverage and payment rates, and enough radiologists and technologists to perform and read scans. Referring physicians generally have no obligation to send patients to Lumexa. Government programs usually pay according to set fee schedules, so raising its charges does not generally increase those payments. Centers need licenses and accreditation, while state restrictions on corporate medical practice and fee splitting limit how Lumexa may structure its relationships with physicians and require it to preserve their medical judgment.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Lumexa Imaging’s results hinge on physician referrals for MRI and CT scans, insurer reimbursement and the performance of its health-system joint ventures.
RadNet, Inc. competes with Lumexa Imaging for physician-referred patients needing MRI, CT and other scans; both operate outpatient imaging centers, including through health-system joint ventures. Watch RadNet’s imaging-center revenue rather than its software and AI sales for the closer comparison with Lumexa’s business.
Fed Interest Rate Decision
Lumexa’s Fed-linked rate backdrop matters because it can lift or ease SOFR, the benchmark rate on its $825 million term loan, changing interest paid and cash left for imaging operations.
Expected4.0%Last release4.0%
If it comes in above expectations
If policy rates rise more than expected, SOFR-linked interest expense on Lumexa’s term loan may increase, leaving less cash to operate and invest in its imaging centers and radiology services.
If it comes in below expectations
If policy rates rise less than expected or fall, SOFR-linked interest expense may be lower than anticipated, leaving Lumexa more cash for its imaging operations and investment.
RadNet, Inc. earningsRDNT
RadNet’s report will show what its imaging centers earn from scans, a read on demand and reimbursement for the physician-referred patients it and Lumexa Imaging Holdings compete to serve.
Focus on RadNet’s imaging-center revenue, not its software and AI sales. Stronger center revenue would suggest the shared market for referred scans has firmer demand or reimbursement, a more supportive backdrop for Lumexa’s centers; weaker revenue would flag possible pressure in that market, but would not prove Lumexa’s own revenue is falling.
Lumexa Imaging Holdings, Inc. earningsThis company
Lumexa Imaging Holdings’ report will show whether its imaging centers and radiologists are turning more scans into enough revenue to cover fixed costs.
Read outpatient same-center scan volume beside revenue per scan, then compare professional revenue per interpretation with operating cash flow. Rising volume and revenue per service, with cash flow holding up, would show referrals and reimbursement supporting a high-fixed-cost business; more scans but weaker revenue per service, or continued cash-flow pressure, would show that revenue may not be keeping pace with costs and debt payments.